All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Circassia plays long game with £175m London IPO

UK biotech firm Circassia has not yet launched bookbuilding on its IPO, despite launching almost three weeks ago. The deal was launched after a run of deals in the US, which have since seen rocky aftermarket performance.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree